113 related articles for article (PubMed ID: 16773207)
1. A domain responsible for HIF-1alpha degradation by YC-1, a novel anticancer agent.
Kim HL; Yeo EJ; Chun YS; Park JW
Int J Oncol; 2006 Jul; 29(1):255-60. PubMed ID: 16773207
[TBL] [Abstract][Full Text] [Related]
2. YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt/NF-kappaB signaling to HIF-1alpha accumulation during hypoxia.
Sun HL; Liu YN; Huang YT; Pan SL; Huang DY; Guh JH; Lee FY; Kuo SC; Teng CM
Oncogene; 2007 Jun; 26(27):3941-51. PubMed ID: 17213816
[TBL] [Abstract][Full Text] [Related]
3. Preclinical evaluation of YC-1, a HIF inhibitor, for the prevention of tumor spreading.
Shin DH; Kim JH; Jung YJ; Kim KE; Jeong JM; Chun YS; Park JW
Cancer Lett; 2007 Sep; 255(1):107-16. PubMed ID: 17502124
[TBL] [Abstract][Full Text] [Related]
4. Effects of YC-1 on hypoxia-inducible factor 1-driven transcription activity, cell proliferative vitality, and apoptosis in hypoxic human pancreatic cancer cells.
Zhao Q; Du J; Gu H; Teng X; Zhang Q; Qin H; Liu N
Pancreas; 2007 Mar; 34(2):242-7. PubMed ID: 17312464
[TBL] [Abstract][Full Text] [Related]
5. Identification of thioredoxin-interacting protein 1 as a hypoxia-inducible factor 1alpha-induced gene in pancreatic cancer.
Baker AF; Koh MY; Williams RR; James B; Wang H; Tate WR; Gallegos A; Von Hoff DD; Han H; Powis G
Pancreas; 2008 Mar; 36(2):178-86. PubMed ID: 18376310
[TBL] [Abstract][Full Text] [Related]
6. Effects of YC-1 targeting hypoxia-inducible factor 1 alpha in oesophageal squamous carcinoma cell line Eca109 cells.
Feng Y; Zhu H; Ling T; Hao B; Zhang G; Shi R
Cell Biol Int; 2011 May; 35(5):491-7. PubMed ID: 20977428
[TBL] [Abstract][Full Text] [Related]
7. [Impact of RNA interference targeting hypoxia-inducible factor-1alpha on chemosensitivity in esophageal squamous cell carcinoma cells under hypoxia].
Wu XA; Sun Y; Fan QX; Wang LX; Wang RL; Zhang L
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(37):2640-4. PubMed ID: 18162154
[TBL] [Abstract][Full Text] [Related]
8. [Inhibitory effect of YC-1 on induction of VEGF and GPI genes in hypoxic human pancreatic cancer cells].
Du J; Zhao Q; Gu H; Teng XL; Qin H; Liu NZ
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):486-9. PubMed ID: 17147109
[TBL] [Abstract][Full Text] [Related]
9. Cell type-specific, topoisomerase II-dependent inhibition of hypoxia-inducible factor-1alpha protein accumulation by NSC 644221.
Creighton-Gutteridge M; Cardellina JH; Stephen AG; Rapisarda A; Uranchimeg B; Hite K; Denny WA; Shoemaker RH; Melillo G
Clin Cancer Res; 2007 Feb; 13(3):1010-8. PubMed ID: 17289897
[TBL] [Abstract][Full Text] [Related]
10. Bafilomycin induces the p21-mediated growth inhibition of cancer cells under hypoxic conditions by expressing hypoxia-inducible factor-1alpha.
Lim JH; Park JW; Kim MS; Park SK; Johnson RS; Chun YS
Mol Pharmacol; 2006 Dec; 70(6):1856-65. PubMed ID: 16940187
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer.
Hiraga T; Kizaka-Kondoh S; Hirota K; Hiraoka M; Yoneda T
Cancer Res; 2007 May; 67(9):4157-63. PubMed ID: 17483326
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of hypoxia-induced increase of blood-brain barrier permeability by YC-1 through the antagonism of HIF-1alpha accumulation and VEGF expression.
Yeh WL; Lu DY; Lin CJ; Liou HC; Fu WM
Mol Pharmacol; 2007 Aug; 72(2):440-9. PubMed ID: 17513385
[TBL] [Abstract][Full Text] [Related]
13. UVC inhibits HIF-1alpha protein translation by a DNA damage- and topoisomerase I-independent pathway.
Rapisarda A; Melillo G
Oncogene; 2007 Oct; 26(48):6875-84. PubMed ID: 17496931
[TBL] [Abstract][Full Text] [Related]
14. Suppression of hypoxia inducible factor-1alpha (HIF-1alpha) by YC-1 is dependent on murine double minute 2 (Mdm2).
Lau CK; Yang ZF; Lam CT; Tam KH; Poon RT; Fan ST
Biochem Biophys Res Commun; 2006 Oct; 348(4):1443-8. PubMed ID: 16919599
[TBL] [Abstract][Full Text] [Related]
15. D-glucosamine down-regulates HIF-1alpha through inhibition of protein translation in DU145 prostate cancer cells.
Park JY; Park JW; Suh SI; Baek WK
Biochem Biophys Res Commun; 2009 Apr; 382(1):96-101. PubMed ID: 19254699
[TBL] [Abstract][Full Text] [Related]
16. Physical and functional interaction of Runt-related protein 1 with hypoxia-inducible factor-1alpha.
Peng ZG; Zhou MY; Huang Y; Qiu JH; Wang LS; Liao SH; Dong S; Chen GQ
Oncogene; 2008 Jan; 27(6):839-47. PubMed ID: 17684492
[TBL] [Abstract][Full Text] [Related]
17. A novel benzimidazole analogue inhibits the hypoxia-inducible factor (HIF)-1 pathway.
Won MS; Im N; Park S; Boovanahalli SK; Jin Y; Jin X; Chung KS; Kang M; Lee K; Park SK; Kim HM; Kwon BM; Lee JJ; Lee K
Biochem Biophys Res Commun; 2009 Jul; 385(1):16-21. PubMed ID: 19433063
[TBL] [Abstract][Full Text] [Related]
18. Inhibitor of DNA binding 1 activates vascular endothelial growth factor through enhancing the stability and activity of hypoxia-inducible factor-1alpha.
Kim HJ; Chung H; Yoo YG; Kim H; Lee JY; Lee MO; Kong G
Mol Cancer Res; 2007 Apr; 5(4):321-9. PubMed ID: 17426247
[TBL] [Abstract][Full Text] [Related]
19. Activating transcription factor 2 increases transactivation and protein stability of hypoxia-inducible factor 1alpha in hepatocytes.
Choi JH; Cho HK; Choi YH; Cheong J
Biochem J; 2009 Nov; 424(2):285-96. PubMed ID: 19712049
[TBL] [Abstract][Full Text] [Related]
20. A quassinoid 6alpha-tigloyloxychaparrinone inhibits hypoxia-inducible factor-1 pathway by inhibition of eukaryotic translation initiation factor 4E phosphorylation.
Jin X; Jin HR; Lee D; Lee JH; Kim SK; Lee JJ
Eur J Pharmacol; 2008 Sep; 592(1-3):41-7. PubMed ID: 18639543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
